The estimated Net Worth of Randall Kaye is at least $548 Tysiąc dollars as of 23 December 2015. Randall Kaye owns over 1,000 units of Axsome Therapeutics Inc stock worth over $548,183 and over the last 9 years Randall sold AXSM stock worth over $0.
Randall has made over 1 trades of the Axsome Therapeutics Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently Randall bought 1,000 units of AXSM stock worth $9,030 on 23 December 2015.
The largest trade Randall's ever made was buying 1,000 units of Axsome Therapeutics Inc stock on 23 December 2015 worth over $9,030. On average, Randall trades about 500 units every 0 days since 2015. As of 23 December 2015 Randall still owns at least 6,022 units of Axsome Therapeutics Inc stock.
You can see the complete history of Randall Kaye stock trades at the bottom of the page.
Randall's mailing address filed with the SEC is 25 Broadway, New York, NY 10004, USA.
Over the last 9 years, insiders at Axsome Therapeutics Inc have traded over $3,013,485 worth of Axsome Therapeutics Inc stock and bought 82,512 units worth $1,366,003 . The most active insiders traders include Roger Jeffs, Susan Mahony oraz Mark Coleman. On average, Axsome Therapeutics Inc executives and independent directors trade stock every 114 days with the average trade being worth of $1,405,685. The most recent stock trade was executed by Mark E Saad on 11 September 2024, trading 11,016 units of AXSM stock currently worth $40,429.
axsome therapeutics is a biopharmaceutical company developing novel therapies for the treatment of cns disorders. axsome has a balanced portfolio of clinical development stage as well as research stage product candidates. the company is based in new york city.
Axsome Therapeutics Inc executives and other stock owners filed with the SEC include: